COVID-19 vaccination information and updates
Vaccination eligibility is opening up quickly in Oregon. All Oregonians 16 and older are eligible to receive the COVID-19 vaccine.
Vaccination is free. You do not need health insurance, a Social Security number or an identification card to get vaccinated. Your vaccination record will be kept private.
Who Can Get vaccinated?
All Oregonians 16 and older are eligible to receive the COVID-19 vaccine.
Vaccination is the safest, most effective and reliable way to keep yourself, your family and the community healthy and safe.
Schedule your vaccination
Call to schedule
- Call 541-789-2813, Option 2 from 8 a.m. to 5 p.m., Monday through Friday to schedule an appointment.
- Para hablar con un representante de habla hispana, llame al 541-789-2813, Opción 3, de 9 a.m. a 4 p.m., de lunes a viernes.
Vaccination appointments may be reserved online through our open scheduling process.
Latino community members
Information about getting vaccinated at Asante is available in English and Español.
Hours of Operation
- 7:30 a.m. - 4:00 p.m. Monday
- 11:30 a.m. - 7:30 p.m. Tuesday
- 7:30 a.m. - 4:00 p.m. Wednesday
- 10 a.m. - 5:30 p.m. Thursday
- 7:30 a.m. - 4:00 p.m. Friday
Grants Pass Clinic
- 8 a.m. - 5:30 p.m. Saturday
- 8 a.m. - 5:30 p.m. Sunday
The vaccine is currently not available to the general public
Once the vaccine is widely available, Oregonians will have access to a vaccine through a doctor’s office, pharmacy or other location. Vaccination will be the safest, most effective and reliable way to keep yourself, your family and the community healthy and safe from the pandemic.
Until a vaccine is available to everyone, please continue taking actions to help prevent the spread of COVID-19:
At present, there are many opportunities for clinical professionals to assist with the vaccination clinics and help our community move closer to immunity. If you are interested in volunteering, we need your help! Complete this form to indicate your interest in volunteering in one of our vaccination clinics.
Frequently Asked Questions
As part of our government’s response to COVID-19 several pharmaceutical companies are working on producing a vaccine. Per the Centers for Disease Control and Prevention (CDC), the intent of the vaccine is to support the human body in developing immunity to the virus.
Asante’s goal is to provide you with current information about a COVID-19 vaccination and its distribution when it becomes available.
Can I get COVID-19 from the vaccine?
No, the Pfizer-BioNTech COVID-19 does not contain live SARS-CoV-2 virus. Future vaccines in the pipeline such as the one developed by AstraZeneca do contain a live viral vector; others are likely to contain viral components and proteins as well.
Is the COVID-19 vaccine safe?
Safety is the number one priority of the CDC and FDA. Clinical trials are used to authorize or license vaccines for use.
The FDA authorized the Pfizer-BioNTech COVID-19 vaccine under an Emergency Use Authorization (EUA) based on two months of safety data. In most people, the vaccine causes only mild to moderate, short-lived side effects. Pfizer must collect six months of data to apply for full approval.
Getting vaccinated is the safest way to protect yourself from COVID-19.
How effective is the COVID-19 vaccine?
The Pfizer-BioNTech vaccine was found to be 95% effective at preventing infection with two doses in Phase 3 clinical trials.
When will the COVID-19 vaccine be available?
Pfizer, the first company to submit for Emergency Use Authorization (EUA), was approved Dec. 11. Southern Oregon will receive COVID-19 vaccine doses as early as Dec. 15.
Wider distribution of the COVID-19 vaccine will likely come in mid to late 2021 for the general public.
Who can get the COVID-19 vaccine?
The FDA has authorized emergency use of the Pfizer vaccine to prevent COVID-19 in people older than 16 year of age.
Asante will follow recommendations from the Oregon Health Authority and the CDC regarding initial distribution of the limited supply. Asante’s goal is a fair and equitable distribution of the vaccine. We will ensure the top priority for vaccination are staff and providers working in direct patient locations. Further prioritizations will be announced as vaccine supply is better understood.
The vaccine was not tested in pregnant women; at this point there is not data on safety and effectiveness in this population. Data are not available to assess the effects of the Pfizer-BioNTech COVID-19 vaccine on the breastfed infant.